Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
06/2010
06/17/2010US20100151454 Microfluidic apparatus, systems, and methods for performing molecular reactions
06/17/2010US20100151453 Dot1 histone methyltransferases as a target for identifying therapeutic agents for leukemia
06/17/2010US20100151452 Methods and Systems for Searching for Regulators of the Fer Protein and for Monitoring the Effects of the Fer Protein
06/17/2010US20100151451 Method for Identifying the Genotype in Position 171 of the Ovine Prion Protein as well as Kits for Implementing said Method
06/17/2010US20100151450 Classification Method
06/17/2010US20100151449 Method for poduction of l-amino acids by fermentation
06/17/2010US20100151448 Asymmetric PCR Amplification, its Special Primer and Application
06/17/2010US20100151447 Method for double staining in immunohistochemistry
06/17/2010US20100151446 Method for counting and segmenting viral particles in an image
06/17/2010US20100151445 Multiplex Method for Detecting an Infection
06/17/2010US20100151444 Detection method for human pappilomavirus (HPV) and its application in cervical cancer
06/17/2010US20100151443 Microfluid system and method to test for target molecules in a biological sample
06/17/2010US20100151442 Method for detecting emerging pandemic influenza
06/17/2010US20100151441 Human Cytomegalovirus Latency Promoting Genes, Related Virus Variants and Methods of Use
06/17/2010US20100151440 High throughput screening platform for high ethanol
06/17/2010US20100151439 Enzymatic Assays for a Droplet Actuator
06/17/2010US20100151435 Compositions and methods for tissue preservation
06/17/2010US20100151050 Method for evaluation of compound using RSK1
06/17/2010US20100151024 Therapeutic agent for ulcerative colitis
06/17/2010US20100151006 Cancer therapy sensitizer
06/17/2010US20100151004 Modulation of drug sensitivity
06/17/2010US20100150966 Method for the diagnosis of tuberculosis
06/17/2010US20100150962 Polypeptide fragments of the hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits
06/17/2010US20100150944 Methods and compositions for diagnosis and treatment of depression and anxiety
06/17/2010US20100150941 Hemagglutinin antibody and uses thereof
06/17/2010US20100150930 Mage-11 as a marker for endometrial receptivity to embryo transplantation and a marker and therapeutic target in castration-recurrent prostate cancer
06/17/2010US20100150929 Peptide Associated with Rheumatic Fever (PARF) and Its Use as a Diagnostic Marker
06/17/2010US20100150909 PTHrP-DERIVED MODULATORS OF SMOOTH MUSCLE PROLIFERATION
06/17/2010US20100150901 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor
06/17/2010US20100150877 Osteopontin for the Prediction and Treatment of Cardiovascular Diseases
06/17/2010US20100150875 Indefinite culture of human adult glia without immortalization and therapeutic uses thereof
06/17/2010US20100150868 Methods of Individually Optimizing Treatment for an Inflammation Associated Disease
06/17/2010US20100150862 Methods of modulating maternal-fetal tolerance
06/17/2010US20100150842 Method and Kit for Detecting Resistance in Living Organisms
06/17/2010US20100150840 Small-molecule agonists for type-2 orexin receptor
06/17/2010US20100150839 Compositions and Methods for Modulating Cognitive Function
06/17/2010US20100150838 Methods for evaluating osteoarthritis risk
06/17/2010US20100147706 System and method for coding information on a biosensor test strip
06/17/2010DE102009046430A1 Teststreifen zum Nachweisen gastritischer Probleme und Nachweisverfahren dafür Test strips for detecting gastritis, problems and methods of verification for
06/17/2010DE102008062372B3 Nachweiskonjugat und Verfahren zur Analyse Detection conjugate, and methods of analysis
06/17/2010DE102008061866A1 Use of ionic liquid comprising e.g. pyridinium cation for increasing the half-life of cofactors e.g. NADPH and NADH
06/17/2010DE102008061774A1 Indexierung von Nukleinsäure-Populationen Indexing of nucleic acid populations
06/17/2010DE102008061772A1 Verfahren zur Untersuchung von Nukleinsäure-Populationen A method for the investigation of nucleic acid populations
06/17/2010DE102008061013A1 In-vitro-Assay zur Frühdiagnostik von Diabetes mellitus Typ 1 In vitro assay for the early diagnosis of type 1 diabetes mellitus
06/17/2010DE102008058984A1 Determining an effective or ineffective chemotherapeutic drugs for patients by individual in vitro testing of live tumor cells before or during therapy, where the drugs are further tested in presence of e.g. oxygen deficiency and glucose
06/17/2010DE102008054494A1 New nucleic acid encoding a fusion protein that comprises specific amino acid sequences and a matrix-metalloprotease
06/17/2010CA2783562A1 Ratiometric pre-rrna analysis
06/17/2010CA2749322A1 Methods and compositions for cancer prognosis
06/17/2010CA2747244A1 Cell-based detection of apf through its interaction with ckap4 for diagnosis of interstitial cystitis
06/17/2010CA2746632A1 Classification of nucleic acid templates
06/17/2010CA2746339A1 Proliferation-associated modulation of the splicing of the integrin alpha 6 isoforms
06/17/2010CA2746273A1 Small molecule immunomodulators for alzheimer's disease
06/17/2010CA2746021A1 Use of cyclodextrins to improve the specificity, sensitivity and yield of nucleic acid amplification reactions
06/17/2010CA2745849A1 Novel human endogenous retorviral erv3 variant and uses thereof for diagnosing ovarian cancer
06/17/2010CA2744004A1 Compositions and methods for detecting small rnas, and uses thereof
06/16/2010EP2196799A2 Buffers for electrophoresis and use thereof
06/16/2010EP2196547A1 Method for predicting the response to a treatment with a HER dimerization inhibitor
06/16/2010EP2196546A1 Methods for predicting the response of multiple sclerosis patients to interferon therapy and diagnosing multiple sclerosis
06/16/2010EP2196545A1 Methods for predicting the response of multiple sclerosis patients to interferon therapy and diagnosing multiple sclerosis
06/16/2010EP2196544A1 Kit for ligation detection assays using codeable labels
06/16/2010EP2196543A1 Compositions and methods for micro-rna expression profiling of hepatocellular cancer
06/16/2010EP2196542A1 Compositions and methods for micro-rna expression profiling of colorectal cancer
06/16/2010EP2196537A1 Method for synthesis of single- or double-stranded dna, and kit for the synthesis
06/16/2010EP2196474A2 Therapeutic targets in cancer
06/16/2010EP2196473A1 Mycobacterial antigens expressed during latency
06/16/2010EP2196215A1 Method for making an immunogenic composition with Hoc fusion proteins and Soc fusion proteins
06/16/2010EP2196214A1 Method for making an immunogenic composition with Hoc fusion proteins and/or Soc fusion proteins
06/16/2010EP2195655A1 Rapid assessment of upper respiratory conditions
06/16/2010EP2195648A1 High-resolution molecular graphene sensor comprising an aperture in the graphene layer
06/16/2010EP2195468A1 Composition comprising an oligonucleotide mixture for improved detection of human papillomavirus genotypes
06/16/2010EP2195467A1 Tumor grading and cancer prognosis
06/16/2010EP2195466A2 Biological specimen collection and transport system and methods of use
06/16/2010EP2195465A2 Polynucleotide backbones for complexing proteins
06/16/2010EP2195464A2 Primers for pcr amplification comprising abasic parts within the primer sequences
06/16/2010EP2195462A1 Prediction of sleep parameter and response to sleep-inducing compound based on per3 vntr genotype
06/16/2010EP2195460A2 Genetic test for liver copper accumulation in dogs and low copper pet diet
06/16/2010EP2195459A2 Nucleobase characterisation
06/16/2010EP2195457A1 Single cell based reporter assay to monitor gene expression patterns with high spatio-temporal resolution
06/16/2010EP2195456A2 Use of polymorphisms in the tmem132d gene in the prediction and treatment of anxiety disorders
06/16/2010EP2195454A1 Cell detection, monitoring and isolation method
06/16/2010EP2195453A2 Method of amplifying nucleic acid
06/16/2010EP2195451A1 Expression profiles of biomarker genes in notch mediated cancers
06/16/2010EP2195450A2 Methods of using mirna for detection of in vivo cell death
06/16/2010EP2195449A1 Methods and kits for selectively amplifying, detecting or quantifying target dna with specific end sequences
06/16/2010EP2195448A1 Method to predict iris color
06/16/2010EP2195447A1 Nucleotide triphosphate with an electroactive label conjugated to the gamma phosphate
06/16/2010EP2195446A2 Self-actuating signal producing detection devices and methods
06/16/2010EP2195445A1 Biosensor antibody functional mapping
06/16/2010EP2195113A2 Microfluidic method and system for enzyme inhibition activity screening
06/16/2010EP2195005A2 Gene signature for the prediction of radiation therapy response
06/16/2010EP1627917B1 NUCLEIC ACID CONSTRUCT CONTAINING HEPATITIS C VIRUS (HCV) OF GENOCYPE 2a GENOME-ORIGIN NUCLEIC ACID AND CELL HAVING THE NUCLEIC ACID CONSTRUCT TRANSFERRED THEREINTO
06/16/2010EP1622921B1 Variants of beta-glucosidases
06/16/2010EP1587816B1 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection
06/16/2010EP1579004B1 Screening methods for identification of efficient pre-trans-splicing molecules
06/16/2010EP1412487B1 Assay electrodes having immobilized lipid/protein layers and methods of making and using the same
06/16/2010EP0938320B1 Method enabling use of extracellular rna extracted from plasma or serum to detect, monitor or evaluate cancer
06/16/2010CN1997389B Needle-free administration of FeLV vaccines
06/16/2010CN1974786B Process of screening phosphonomycin producing strain
06/16/2010CN1932039B Single molecular nucleic acid sequencing process for exonuclease-nanometer hole
06/16/2010CN1904034B Novel bacterium and vaccine